Through Charles River Discovery Services, your preclinical program can benefit from the extensive expertise and support of industry-recognized drug discovery leaders and state-of-the-art imaging services. Working side-by-side with therapeutic area and disease model experts, our staff will collaborate with you on protocol design, implementation, optimization and validation. This multidisciplinary collaboration helps to ensure data quality and meaningful interpretation of results across the oncology, CNS, inflammation, metabolic and cardiovascular therapeutic areas.
Imaging Services by Modality
|
|
|
imaging, Imaging services, Magnetic Resonance Imaging, MRI, micro-Computed Tomography, micro-CT, Positron Emission Tomography, PET
Imaging | Charles River Discovery Services
Imaging technologies, such as Magnetic Resonance Imaging (MRI), Computed Tomography, and Positron Emission Tomography (PET), can increase lead candidate selection efficiency by providing more highly predictive data early in the drug development process.